Early 1990s
Transdermal Delivery Research Begins
In the early 1990’s, the CEO of HypoSpray Pharma, Kenneth B. Kirby, began researching ways to improve the safety and efficiency of transdermal drug delivery. He began by investigating which compounds could transmigrate the skin readily and rapidly, without the need to overcome the natural protective barriers of the human skin.